Process development
Process development

Revolutionizing Cell Therapy Manufacturing: Cheaper and Accessible
📰 Getting the Economical Edge on Cheaper Cell Therapy Manufacturing explores Alder Therapeutics' cost-effective approach to therapy development. 💰🔬🧪🔬🔬🌱

CEO of Généthon Reveals Future of Gene Therapy
🔍 Frédéric Revah, CEO of Généthon, reflects on the past, present, and future of the organization in an interview. 🧬 Généthon was created in 1990 with a focus on gene therapy research for rare genetic diseases. 💡 Revah discusses the challenges of financing development for rare diseases and the need for equity in distribution. 🏭 Généthon is working on improving bioprocessing and reducing the cost of production for gene therapies. 🤝 The organization collaborates with partners in various fields to advance their research. ⚙️ Exciting developments include producing AAV in plants and using artificial intelligence to optimize bioreactors. ❌ The industry faces challenges such as improving the full-to-empty ratio of virus capsids. ❗️ Revah comments on the Pfizer incident and assures that Généthon is closely monitoring safety in their own clinical trial.

Europe’s Cluster Conference: Boosting Green Digital and Biotech Leadership
💥 More than 900 experts from clusters and the EU Commission gathered in Brussels for the European Cluster Conference. 🌍💪🏼

Unveiling Key Characteristics of Nucleic Acid Therapeutics
📰 Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics and Their Carriers discusses methods for identifying important quality attributes in nucleic acid therapeutics and their delivery systems. 🔬💡🌡️⚖️

Protein Flags CAR-T Cells Weakens Cancer Therapy
🧬 Researchers discovered that B7H6 protein can signal NK cells to eliminate CAR-T cells, affecting cancer therapies. 🚫🔬










